Skip to main content
NIH funding notice PA-10-250

Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R21)

Closed on September 7, 2013.

Posted
August 4, 2010
Close date
September 7, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $318,335 in first-year total cost, median $159,168.

Most frequent study sections

  1. Neuroscience and Behavior Study Section[AA-4]2

Most frequent institutions

  1. CENTRE FOR ADDICTION AND MENTAL HEALTH1
  2. UNIVERSITY OF TENNESSEE HEALTH SCI CTR1
Competing awards under PA-10-250 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Fetal cerebrovascular eCB system as a target of maternal alcohol consumption1R21AA022433-01BUKIYA, ANNAUNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN$178,125AA
2014Fatty Acid Amide Hydrolase in treatment seeking alcohol dependent individuals1R21AA022246-01A1BOILEAU, ISABELLECENTRE FOR ADDICTION AND MENTAL HEALTH, ON$140,210AA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-10-250: Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R21) | ScienceDex | ConductScience